Pasireotide (aspartate) (trifluoroacetate salt)

Pasireotide (aspartate) (trifluoroacetate salt)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
Cay24092-1 1 mg -

6 - 10 business days*

212.00€
Cay24092-5 5 mg -

6 - 10 business days*

839.00€
Cay24092-10 10 mg -

6 - 10 business days*

1,362.00€
 
Pasireotide is a somatostatin receptor (SSTR) agonist that binds selectively to SST1, SST2, SST3,... more
Product information "Pasireotide (aspartate) (trifluoroacetate salt)"
Pasireotide is a somatostatin receptor (SSTR) agonist that binds selectively to SST1, SST2, SST3, and SST5 over SST4 (IC50s = 9.3, 1, 1.5, 0.16, and >100 nM, respectively, for human recombinant receptors). It dose-dependently inhibits growth hormone release stimulated by growth hormone-releasing hormone (GHRH) in primary rat anterior pituitary cells and inhibits adrenocorticotropic hormone (ACTH) secretion by some primary human corticotrope adenomas at a concentration of 10 nM. Pasireotide (10 nM) also inhibits ACTH release from and proliferation of mouse AtT20 pituitary corticotrope cells in vitro and inhibits tumor growth of subcutaneously implanted AtT20 cells in vivo in nude mice when administered at a dose of 1.5 µg per day. Pasireotide (0.03 mg/kg) decreases plasma ACTH concentrations and tumor size in dogs with ACTH-dependent Cushing's disease. Formulations containing pasireotide have been used in the treatment of acromegaly and Cushing's disease.Formal Name: cyclo[(2R)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl], L-aspartate (1:2), trifluoroacetate salt. Synonyms: SOM230. Molecular Formula: C58H66N10O9 . 2C4H7NO4 . XCF3COOH. Formula Weight: 1313.4. Purity: >95%. Formulation: (Request formulation change), A crystalline solid. Solubility: DMF: 33 mg/ml, DMSO: 33 mg/ml, Ethanol: 33 mg/ml, Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/ml. SMILES: O=C([C@H](CC1=CC=CC=C1)N2)N3[C@](C[C@@H](OC(NCCN)=O)C3)([H])C(N[C@H](C4=CC=CC=C4)C(N[C@H](CC5=CNC6=C5C=CC=C6)C(N[C@@H](CCCCN)C(N[C@@H](CC7=CC=C(OCC8=CC=CC=C8)C=C7)C2=O)=O)=O)=O)=O.OC(C[C@H](N)C(O)=O)=O.OC(C[C@H](N)C(O)=O)=O.FC(F)(C(O)=O)F. InChi Code: InChI=1S/C58H66N10O9.2C4H7NO4.C2HF3O2/c59-27-13-12-22-46-52(69)64-47(30-38-23-25-42(26-24-38)76-36-39-16-6-2-7-17-39)53(70)66-49(31-37-14-4-1-5-15-37)57(74)68-35-43(77-58(75)61-29-28-60)33-50(68)55(72)67-51(40-18-8-3-9-19-40)56(73)65-48(54(71)63-46)32-41-34-62-45-21-11-10-20-44(41)45,2*5-2(4(8)9)1-3(6)7,3-2(4,5)1(6)7/h1-11,14-21,23-26,34,43,46-51,62H,12-13,22,27-33,35-36,59-60H2,(H,61,75)(H,63,71)(H,64,69)(H,65,73)(H,66,70)(H,67,72),2*2H,1,5H2,(H,6,7)(H,8,9),(H,6,7)/t43-,46+,47+,48-,49+,50+,51-,2*2-,/m100./s1. InChi Key: LBWKTPKTMIBIDM-DOKMMQMOSA-N.
Keywords: SOM230, cyclo[(2R)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl], L-aspartate (1:2), trifluoroacetate salt
Supplier: Cayman Chemical
Supplier-Nr: 24092

Properties

Application: Somatostatin receptor agonist
MW: 1313.4 D
Formula: C58H66N10O9 . 2C4H7NO4 . XCF3COOH
Purity: >95%
Format: Crystalline Solid

Database Information

KEGG ID : K04218 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +20°C (International: -20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Pasireotide (aspartate) (trifluoroacetate salt)"
Write a review
or to review a product.
Viewed